FDA Labeling Violations: Allergen Failures, Misbranding Penalties, and Enforcement

Last updated: 2026-04-06 — ComplianceStack Editorial Team

Food labeling violations fall under the misbranding provisions of the Federal Food, Drug, and Cosmetic Act (21 USC 343). A food is misbranded if its labeling is false or misleading, if it fails to declare required information (ingredients, allergens, nutrition facts), or if the label does not conform to FDA formatting requirements. Allergen labeling failures are the single most common trigger for Class I food recalls — the category with the highest health risk. Under FALCPA (Food Allergen Labeling and Consumer Protection Act of 2004, as amended by the FASTER Act of 2021), all packaged foods must declare the presence of nine major allergens: milk, eggs, fish, crustacean shellfish, tree nuts, peanuts, wheat, soybeans, and sesame. In January 2024, a 25-year-old woman died from anaphylaxis after eating a Florentine Cookie from Stew Leonard's that contained undeclared peanuts and eggs. FDA issued a warning letter in November 2024. Misbranding is a federal crime.

Regulatory Authority: 21 USC 343 (Misbranding); 21 USC 343(w) (Allergen Labeling, FALCPA); FASTER Act of 2021 (Sesame as 9th Major Allergen); 21 CFR 101.9 (Nutrition Facts); 21 CFR 101.4 (Ingredient Labeling); 21 USC 331 (Prohibited Acts); 21 USC 333 (Criminal Penalties); 21 USC 334 (Seizure); FDA Guidance for Industry: Food Allergen Labeling, Edition 5 (January 2025)

Penalty Tier Breakdown

Undeclared Major Allergen — Class I Recall and Warning Letter

Immediate Class I recall; warning letter with re-inspection fees ($318/hour FY2025); potential criminal prosecution if pattern of negligence

Annual max: No cap — each mislabeled product lot is a separate violation; re-inspection fees accumulate per hour of FDA follow-up

Failure to declare a major allergen on a food label is the most common cause of Class I food recalls in the United States. Under FALCPA and the FASTER Act, packaged foods must declare the presence of nine major allergens either in the ingredient list (using the common name of the food source) or in a separate 'Contains' statement immediately after the ingredient list. A single undeclared allergen makes the entire product misbranded and adulterated — subject to recall, seizure, and criminal penalties. FDA tracks allergen recalls closely and has identified undeclared allergens as the leading cause of Class I recalls in every year since FALCPA enforcement began.

Example: In January 2024, a 25-year-old woman with a known peanut allergy died after consuming a Florentine Cookie sold by Stew Leonard's that contained undeclared peanuts and eggs. The label had no allergen statement. FDA inspected the Danbury, Connecticut facility and issued a warning letter (November 2024) citing misbranding violations for Florentine Cookies and Rainbow Cookies.

Nutrition Facts Violations — Warning Letter and Corrective Action

Warning letter; product deemed misbranded; re-inspection fees if follow-up inspection required

Annual max: Re-inspection fees at $318/hour (FY2025); no monetary cap on corrective action costs

All packaged foods must bear a Nutrition Facts panel that conforms to FDA's formatting requirements under 21 CFR 101.9. Required elements include: serving size, calories, total fat, saturated fat, trans fat, cholesterol, sodium, total carbohydrate, dietary fiber, total sugars, added sugars, protein, vitamin D, calcium, iron, and potassium. The FDA updated Nutrition Facts requirements in 2020, and products that have not updated their labels are non-compliant. Missing, inaccurate, or improperly formatted Nutrition Facts panels make the product misbranded. While nutrition labeling violations alone rarely trigger recalls, they are frequently cited alongside allergen or ingredient violations in warning letters.

Example: In the Stew Leonard's warning letter (November 2024), FDA cited the Rainbow Cookies for a Nutrition Facts panel that failed to declare added sugars, vitamin D, and potassium — in addition to missing sub-ingredient details like rice flour, fruit juice color, and xanthan gum.

False or Misleading Claims — Seizure and Injunction

Product seizure (21 USC 334); injunction prohibiting distribution (21 USC 332); criminal misdemeanor or felony

Annual max: No cap — each falsely labeled product unit in commerce is a separate violation

A food is misbranded if its labeling is false or misleading in any particular (21 USC 343(a)). This includes false health claims, unauthorized nutrient content claims, misleading product names, false country of origin statements, and deceptive imagery. FDA can seize falsely labeled products and obtain injunctions prohibiting the company from distributing misbranded products. Economically Motivated Adulteration (food fraud) — adding cheaper substitutes or diluting ingredients while maintaining label claims — falls under both misbranding and adulteration provisions. FDA's Office of Criminal Investigations has increased focus on food fraud cases.

Example: FDA has pursued enforcement against companies selling diluted honey labeled as 'pure honey,' olive oil mixed with cheaper seed oils labeled as 'extra virgin,' and fish species substituted with cheaper alternatives while maintaining premium labeling and pricing.

Criminal Prosecution — Repeated or Willful Misbranding

Misdemeanor (first offense): up to $1,000 fine + 1 year imprisonment; Felony (intent to defraud or second offense): up to $10,000 + 3 years

Annual max: Civil money penalties up to $690,000 per individual, $7,000,000 per corporation per proceeding (2025 inflation-adjusted)

Introducing misbranded food into interstate commerce is a federal crime under 21 USC 331(a) and 333. First-offense violations are misdemeanors. Violations committed with intent to defraud or mislead, or by a person with a prior conviction, are felonies. Criminal prosecution for labeling violations is more likely when: (1) the misbranding caused actual illness or death; (2) the company had prior warnings and failed to correct; (3) there is evidence of intentional false labeling for economic gain; or (4) the company concealed the labeling error from FDA. Responsible corporate officers can be held personally liable under the Park Doctrine even without personal knowledge of the violation.

Example: The Park Doctrine (from United States v. Park, 1975) allows FDA to prosecute corporate officers for food safety violations even without proof that the officer personally knew about or participated in the violation — only that they had authority and responsibility to prevent it. This doctrine has been applied in misbranding cases where executives had oversight of labeling operations.

How Penalties Are Calculated

FDA evaluates labeling violations through inspection, product sampling, consumer complaints, and surveillance of the marketplace. Allergen-related enforcement follows an accelerated path because of the immediate health risk: consumer complaint or adverse event → FDA inspection → warning letter (often within weeks rather than months) → recall → criminal referral if warranted. For nutrition and claims violations, enforcement is typically slower — FDA issues guidance and allows compliance periods before pursuing enforcement. The economic impact of labeling violations extends beyond FDA penalties: product recalls cost an average of $10 million per incident (direct costs including logistics, destruction, and testing) plus brand damage and litigation. Allergen-related wrongful death lawsuits can result in multi-million dollar settlements or jury verdicts. The combination of regulatory penalties, recall costs, and civil litigation creates total exposure that dwarfs the statutory fine amounts.

Recent Enforcement Actions

2024 — Stew Leonard's Holdings LLC (Danbury, Connecticut)

Florentine Cookies contained undeclared peanuts and eggs — no allergen statement on label. Rainbow Cookies had missing sub-ingredients and non-compliant Nutrition Facts panel. An anaphylactic death occurred in January 2024 from the mislabeled Florentine Cookie.

Penalty: FDA Warning Letter issued November 18, 2024. Class I recall of Florentine Cookies. The estate of the 25-year-old victim filed a wrongful death lawsuit alleging gross negligence and reckless indifference.

Source: FDA Warning Letter 681214, November 2024; Food Safety News, January 2025

2024 — Undeclared Allergen Recalls — Industry-Wide (Class I)

Undeclared allergens remained the single most common cause of Class I food recalls throughout 2024. The nine major allergens (including sesame, added January 2023 under FASTER Act) accounted for more Class I recalls than pathogen contamination.

Penalty: Hundreds of individual product recalls classified as Class I. Companies face re-inspection fees, warning letters, and escalated enforcement. Repeated allergen failures trigger heightened FDA scrutiny and potential criminal referral.

Source: FDA Enforcement Reports 2024; FDA FALCPA and FASTER Act Enforcement Data

2025 — FDA Allergen Labeling Guidance Update (Edition 5)

Not an enforcement action — FDA published final guidance on food allergen labeling (Edition 5) on January 6, 2025, replacing both draft and final 2022 guidance. The updated guidance clarifies requirements for sesame labeling under the FASTER Act and provides new examples for manufacturers.

Penalty: The updated guidance establishes FDA's current interpretation of allergen labeling requirements. Non-compliance with guidance positions creates enforcement risk even absent immediate action — guidance documents define what FDA considers compliant.

Source: FDA Guidance for Industry, January 2025; Federal Register 90 FR 760

2023 — Economically Motivated Adulteration Cases (Food Fraud)

FDA's Office of Criminal Investigations pursued multiple cases involving food products labeled with false claims — substituted ingredients, diluted products sold at premium prices, and falsified country-of-origin statements

Penalty: Criminal prosecution for misbranding and adulteration under 21 USC 331, 333, and 343. Penalties included fines, imprisonment, and consent decrees prohibiting future distribution.

Source: FDA Economically Motivated Adulteration Program; 2023–2024 FDA Enforcement Data

Understand Your FDA/FSMA Penalty Exposure

Use ComplianceStack's free tools to identify gaps before regulators do.

Take the Quiz → Gap Analyzer →

Frequently Asked Questions

What are the nine major food allergens that must be declared?

Under FALCPA (2004) as amended by the FASTER Act (2021), the nine major food allergens that must be declared on all packaged food labels are: (1) milk, (2) eggs, (3) fish, (4) crustacean shellfish, (5) tree nuts, (6) peanuts, (7) wheat, (8) soybeans, and (9) sesame. Sesame was added effective January 1, 2023. These allergens must be declared either in the ingredient list (using the common name of the food source, e.g., 'whey (milk)') or in a separate 'Contains' statement immediately after the ingredient list (e.g., 'Contains: milk, wheat'). Failure to declare any of these allergens makes the product misbranded under federal law and is the most common trigger for Class I food recalls.

Can a company be prosecuted for an allergen labeling mistake that was unintentional?

Yes. Under 21 USC 333, introducing misbranded food into interstate commerce is a strict liability offense for misdemeanor charges — the government does not need to prove intent. A first-offense misdemeanor carries up to $1,000 fine and 1 year imprisonment. Intent matters for felony charges: if the misbranding was done with intent to defraud or mislead, or if the person has a prior conviction, the offense becomes a felony with up to $10,000 and 3 years. Additionally, under the Park Doctrine, corporate officers with authority and responsibility to prevent food safety violations can be held personally liable even without evidence they knew about the specific labeling error.

Does the 'may contain' advisory statement replace allergen declaration requirements?

No. 'May contain [allergen]' advisory statements are voluntary and do not satisfy the mandatory allergen declaration requirement under FALCPA. If a food contains a major allergen as an ingredient, the allergen must be declared in the ingredient list or a 'Contains' statement — an advisory statement is not a substitute. Advisory statements like 'may contain traces of peanuts' or 'manufactured in a facility that processes tree nuts' are used for unintentional cross-contact during manufacturing. FDA has stated that advisory statements should be truthful and not misleading, and should not be used as a substitute for cGMP practices that prevent cross-contact. The January 2025 guidance (Edition 5) provides updated clarification on the use of advisory statements.